1,955
Views
6
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Nanotherapy for bone repair: milk-derived small extracellular vesicles delivery of icariin

, , , , , , , , & show all
Article: 2169414 | Received 16 Nov 2022, Accepted 26 Dec 2022, Published online: 30 Jan 2023

References

  • Aarts J, Boleij A, Pieters BCH, et al. (2021). Flood control: how milk-derived extracellular vesicles can help to improve the intestinal barrier function and break the gut-joint axis in rheumatoid arthritis. Front Immunol 12:1.
  • Abels ER, Breakefield XO. (2016). Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol 36:301–13.
  • Agrawal AK, Aqil F, Jeyabalan J, et al. (2017). Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine 13:1627–36.
  • Busatto S, Pham A, Suh A, et al. (2019). Organotropic drug delivery: synthetic nanoparticles and extracellular vesicles. Biomed Microdevices 21:46.
  • Familtseva A, Jeremic N, Tyagi SC. (2019). Exosomes: cell-created drug delivery systems. Mol Cell Biochem 459:1–6.
  • Faruqu FN, Xu L, Al-Jamal KT. (2018). Preparation of exosomes for siRNA delivery to cancer cells. J Vis Exp 142:e58814.
  • Go G, Jeon J, Lee G, et al. (2021). Bovine milk extracellular vesicles induce the proliferation and differentiation of osteoblasts and promote osteogenesis in rats. J Food Biochem 45:e13705.
  • Grange C, Skovronova R, Marabese F, Bussolati B. (2019). Stem cell-derived extracellular vesicles and kidney regeneration. Cells 8:1240.
  • Groot M, Lee H. (2020). Sorting mechanisms for MicroRNAs into extracellular vesicles and their associated diseases. Cells 9:1044.
  • Haney MJ, Klyachko NL, Zhao Y, et al. (2015). Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18–30.
  • Herrmann IK, Wood MJA, Fuhrmann G. (2021). Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 16:748–59.
  • Jiang JX, Cherian PP. (2003). Hemichannels formed by connexin 43 play an important role in the release of prostaglandin E(2) by osteocytes in response to mechanical strain. Cell Commun Adhes 10:259–64.
  • Kinoshita Y, Maeda H. (2013). Recent developments of functional scaffolds for craniomaxillofacial bone tissue engineering applications. ScientificWorldJournal 2013:863157.
  • Li S, Liu Y, Tian T, et al. (2021). Bioswitchable delivery of microRNA by framework nucleic acids: application to bone regeneration (Small 47/2021). Small 17:e2104359.
  • Lim HJ, Yoon H, Kim H, et al. (2021). Extracellular vesicle proteomes shed light on the evolutionary, interactive, and functional divergence of their biogenesis mechanisms. Front Cell Dev Biol 9:734950.
  • Luan X, Sansanaphongpricha K, Myers I, et al. (2017). Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38:754–63.
  • Masaoutis C, Theocharis S. (2019). The role of exosomes in bone remodeling: implications for bone physiology and disease. Dis Markers 2019:9417914.
  • Pascucci L, Cocce V, Bonomi A, et al. (2014). Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 192:262–70.
  • Plotkin LI, Speacht TL, Donahue HJ. (2015). Cx43 and mechanotransduction in bone. Curr Osteoporos Rep 13:67–72.
  • Plotkin LI, Stains JP. (2015). Connexins and pannexins in the skeleton: gap junctions, hemichannels and more. Cell Mol Life Sci 72:2853–67.
  • Pomatto MAC, Bussolati B, D’Antico S, et al. (2019). Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs. Mol Ther Methods Clin Dev 13:133–44.
  • Qi S, He J, Zheng H, et al. (2019). Icariin prevents diabetes-induced bone loss in rats by reducing blood glucose and suppressing bone turnover. Molecules 24:1871.
  • Sanwlani R, Fonseka P, Chitti SV, Mathivanan S. (2020). Milk-derived extracellular vesicles in inter-organism, cross-species communication and drug delivery. Proteomes 8:11.
  • Shao H, Im H, Castro CM, et al. (2018). New technologies for analysis of extracellular vesicles. Chem Rev 118:1917–50.
  • Stains JP, Civitelli R. (2016). Connexins in the skeleton. Semin Cell Dev Biol 50:31–9.
  • Tian T, Li Y, Lin Y. (2022). Prospects and challenges of dynamic DNA nanostructures in biomedical applications. Bone Res 10:40.
  • Tome-Carneiro J, Fernandez-Alonso N, Tomas-Zapico C, et al. (2018). Breast milk microRNAs harsh journey towards potential effects in infant development and maturation. Pharmacol Res 132:21–32.
  • Vashisht M, Rani P, Onteru SK, Singh D. (2017). Curcumin encapsulated in milk exosomes resists human digestion and possesses enhanced intestinal permeability in vitro. Appl Biochem Biotechnol 183:993–1007.
  • Wang J, Chen D, Ho EA. (2021). Challenges in the development and establishment of exosome-based drug delivery systems. J Control Release 329:894–906.
  • Wang Z, Wang D, Yang D, et al. (2018). The effect of icariin on bone metabolism and its potential clinical application. Osteoporos Int 29:535–44.
  • Xu S, Yu J, Zhan J, et al. (2017). Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. Biomed Res Int 2017:4684962.
  • Yeo RW, Lai RC, Zhang B, et al. (2013). Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev 65:336–41.
  • Zempleni J, Aguilar-Lozano A, Sadri M, et al. (2017). Biological activities of extracellular vesicles and their cargos from bovine and human milk in humans and implications for infants. J Nutr 147:3–10.
  • Zhang X, Lin X, Liu T, et al. (2019). Osteogenic enhancement between icariin and bone morphogenetic protein 2: a potential osteogenic compound for bone tissue engineering. Front Pharmacol 10:201.